• GlucoStabilizer’s unique HypoDefend insulin dosing algorithm, combined with protective computerized rules and alarm features, protects patients from dangerous hypoglycemic events as well as suppressing the glycemic variability associated with poor outcomes.
   

• HypoDefend settings take into consideration a patient’s sensitivity to insulin and automatically reduces the chance of severe and repeat hypoglycemia.
   

• HypoDefend eliminates rebound high glucoses with specific recommendations for 50% dextrose to bring patients directly to the target level.

GlucoStabilizer is the only insulin dosing tool that can be used for patients able to eat1.

• GlucoStabilizer provides carbohydrate coverage capabilities for exact bolus insulin to keep patients in range, eliminating the need to chase post-meal blood sugars.
   

• Covers nutrition insulin for TPN and regular oral diet; and maintains safe glucose levels
  regardless of meal plan.